Acquired resistance in lung cancer

被引：0
|
作者：
Pamela Feliciano
机构：
来源：
Nature Genetics | 2012年 / 44卷 / 3期
关键词：
D O I：
10.1038/ng.2209
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 241
相关论文
共 50 条
  • [31] Vandetanib Can Overcome the Acquired Resistance to Gefitinib Due to RET Overexpression in Lung Cancer
    Sunohara, M.
    Kawakami, M.
    Watanabe, K.
    Morita, S.
    Kage, H.
    Amano, Y.
    Fukayama, M.
    Nagase, T.
    Ohishi, N.
    Takai, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 95 - 95
  • [32] Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer
    Cao, Lin
    Qin, Zhiyan
    Yu, Ting
    Bai, Xupeng
    Jiang, Shiqin
    Wang, Daifei
    Ning, Fangqing
    Huang, Min
    Jin, Jing
    BIOCHEMICAL PHARMACOLOGY, 2024, 224
  • [33] Transformation to small-cell lung cancer as a mechanism of acquired resistance to crizotinib and alectinib
    Miyamoto, Shingo
    Ikushima, Soichiro
    Ono, Ryu
    Awano, Nobuyasu
    Kondo, Keisuke
    Furuhata, Yoshiaki
    Fukumoto, Kento
    Kumasaka, Toshio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (02) : 170 - 173
  • [34] Acquired resistance in oncogene-addicted non-small-cell lung cancer
    Sini, Claudio
    Tuzi, Alessandro
    Rossi, Giovanni
    Russo, Alessandro
    Pezzuto, Aldo
    FUTURE ONCOLOGY, 2018, 14 (13) : 29 - 40
  • [35] Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer
    Bahcall, Magda
    Sim, Taebo
    Paweletz, Cloud P.
    Patel, Jyoti D.
    Alden, Ryan S.
    Kuang, Yanan
    Sacher, Adrian G.
    Kim, Nam Doo
    Lydon, Christine A.
    Awad, Mark M.
    Jaklitsch, Michael T.
    Sholl, Lynette M.
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    CANCER DISCOVERY, 2016, 6 (12) : 1334 - 1341
  • [36] CLINICAL CHARACTERISTICS OF ACQUIRED RESISTANCE TO GEFITINIB IN NON-SMALL CELL LUNG CANCER
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Shin, Kyeong-Cheol
    Lee, Jae Chol
    Ryu, Jeong Seon
    Jang, Seung Hoon
    Kim, Sun Young
    Jang, Tae Won
    RESPIROLOGY, 2010, 15 : 37 - 37
  • [37] Clinical Characteristics of Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Kim, Kyu-Sik
    Oh, In-Jae
    Ban, Hee Jung
    Lee, Sung Yong
    Jang, Tae Won
    Shin, Kyeong-Cheol
    Lee, Gwan Ho
    Lce, Jae Chol
    Ryu, Jeong-Seon
    Jang, Seung Hoon
    Lee, Jeong Eun
    Kim, Sun Young
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S396 - S397
  • [38] Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
    Roper, Nitin
    Brown, Anna-Leigh
    Wei, Jun S.
    Pack, Svetlana
    Trindade, Christopher
    Kim, Chul
    Restifo, Olivia
    Gao, Shaojian
    Sindiri, Sivasish
    Mehrabadi, Farid
    El Meskini, Rajaa
    Ohler, Zoe Weaver
    Maity, Tapan K.
    Venugopalan, Abhilash
    Cultraro, Constance M.
    Akoth, Elizabeth
    Padiernos, Emerson
    Chen, Haobin
    Kesarwala, Aparna
    Smart, DeeDee K.
    Nilubol, Naris
    Rajan, Arun
    Piotrowska, Zofia
    Xi, Liqiang
    Raffeld, Mark
    Panchenko, Anna R.
    Sahinalp, Cenk
    Hewitt, Stephen
    Hoang, Chuong D.
    Khan, Javed
    Guha, Udayan
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [39] Acquired Resistance to Chemotherapy in Lung Cancer Cells Mediated by Prolonged Nitric Oxide Exposure
    Wongvaranon, Piyaparisorn
    Pongrakhananon, Varisa
    Chunhacha, Preedakorn
    Chanvorachote, Pithi
    ANTICANCER RESEARCH, 2013, 33 (12) : 5433 - 5444
  • [40] The Role of Contactin 1 on Acquired Resistance to Pegylated Arginase in Small Cell Lung Cancer
    Xu, S.
    Yan, S.
    Lam, S. K.
    Cheng, P. N.
    Ho, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S972 - S973
12345